FDA News
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 1–12 of 391 articles
Quick answer
NovaPharmaNews FDA News hub for FDA covers 391 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
FDA approves OTC Rextovy, broadening naloxone access for opioid overdose
FDA · opioid overdose · 6 min
Dr. Sarah MitchellLilly buys 4E in non-opioid pain push: what investors should watch
FDA · moderate to severe acute pain · 6 min
Dr. Sarah MitchellLilly’s early JAK data raises myelofibrosis competition question
FDA · myelofibrosis · 6 min
Dr. Sarah MitchellFDA authorizes emergency pet treatment for New World screwworm
FDA · New World screwworm · 4 min
Dr. Sarah MitchellFDA guidance on sharing potential NDA patent information: what changes now
FDA · 4 min
Dr. Sarah MitchellHillhurst Bio doses first subject in Phase 2a HBI-002 Parkinson's trial
FDA · Parkinson's disease · 5 min
Dr. Sarah MitchellFDA expands Tzield to certain pediatric patients with recent Stage 3 T1D
FDA · diabetes · 5 min
Dr. Sarah MitchellFDA Approves Capivasertib for PTEN-Deficient Prostate Cancer
FDA · prostate cancer · 6 min
Dr. Sarah MitchellFDA approves belzutifan plus pembrolizumab for adjuvant RCC
FDA · renal cell carcinoma · 6 min
Dr. Sarah MitchellFDA MRD guidance in multiple myeloma: what BD teams should track
FDA · multiple myeloma · 6 min
Dr. Sarah MitchellFDA Draft Guidance Updates Payor Communications Rules
FDA · 4 min
Dr. Sarah MitchellAlembic Wins Tentative FDA Nod for First Generic Larotrectinib Capsules
FDA · NTRK fusion–positive solid tumors · 7 min
Dr. Sarah MitchellFrequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.
Explore intelligence